Please Wait.....
Report
Generics Top 5 Emerging Markets Industry Guide 2020-2029
Industry Report I 2025-12-24 I 275 Pages I MarketLine
Generics Top 5 Emerging Markets Industry Guide 2020-2029
Summary
The Emerging 5 Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume , and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- These countries contributed $1,81,062.7 million to the global generics industry in 2024, with a compound annual growth rate (CAGR) of 13.2% between 2007 and 2011. The top 5 emerging countries are expected to reach a value of $2,63,166.9 million in 2029, with a CAGR of 7.8% over the 2024-29 period.
- Within the generics industry, China is the leading country among the top 5 emerging nations, with market revenues of $1,27,482.1 million in 2024. This was followed by India and Brazil with a value of $36,628.0 and $10,309.1 million, respectively.
- China is expected to lead the generics industry in the top five emerging nations, with a value of $1,95,272.1 million in 2029, followed by India and Brazil with expected values of $45,379.6 and $13,858.9 million, respectively.
Scope
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging five generics market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging five generics market
- Leading company profiles reveal details of key generics market players' emerging five operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the emerging five generics market with five year forecasts by both value and volume
- Compares data from Brazil, China, India, Mexico and South Africa, alongside individual chapters on each country
Reasons to Buy
- What was the size of the emerging five generics market by value in 2024?
- What will be the size of the emerging five generics market in 2029?
- What factors are affecting the strength of competition in the emerging five generics market?
- How has the market performed over the last five years?
- How large is the emerging five generics market in relation to its regional counterparts?
Table of Contents
1 Introduction
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions
2 Top 5 Emerging Countries Generics
2.1. Industry Outlook
3 Generics in South Africa
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
4 Macroeconomic Indicators
4.1. Country data
5 Generics in Brazil
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
6 Macroeconomic Indicators
6.1. Country data
7 Generics in China
7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis
8 Macroeconomic Indicators
8.1. Country data
9 Generics in India
9.1. Market Overview
9.2. Market Data
9.3. Market Segmentation
9.4. Market outlook
9.5. Five forces analysis
10 Macroeconomic Indicators
10.1. Country data
11 Generics in Mexico
11.1. Market Overview
11.2. Market Data
11.3. Market Segmentation
11.4. Market outlook
11.5. Five forces analysis
12 Macroeconomic Indicators
12.1. Country data
13 Company Profiles
13.1. Sun Pharmaceutical Industries Ltd
13.2. Viatris Inc
13.3. Novartis AG
13.4. Teva Pharmaceutical Industries Ltd
13.5. Sandoz Group AG
13.6. Hikma Pharmaceuticals Plc
13.7. Sanofi
13.8. Les Laboratoires Servier SAS
13.9. Stada Arzneimittel AG
13.10. Bayer AG
13.11. Lupin Ltd
13.12. Aspen Pharmacare Holdings Ltd
13.13. EMS SA
13.14. Eurofarma Laboratorios SA
13.15. Ache Laboratorios Farmaceuticos SA
13.16. Sino Biopharmaceutical Ltd
13.17. Hansoh Pharmaceutical Group Co Ltd
13.18. CSPC Pharmaceutical Group Ltd
13.19. Dr. Reddy's Laboratories Ltd
13.20. Cipla Ltd
13.21. Aurobindo Pharma Ltd
13.22. PT Indofarma Tbk
13.23. PT Sanbe Farma
13.24. PT Kalbe Farma Tbk
13.25. PT Soho Global Health Tbk
13.26. Friulchem SpA
13.27. DOC Generici SRL
13.28. Recordati SpA
13.29. Daiichi Sankyo Co Ltd
13.30. Sawai Group Holdings Co Ltd
13.31. Toho Holdings Co Ltd
13.32. Towa Pharmaceutical Co Ltd
13.33. Laboratorios Silanes SA de CV
13.34. Pfizer Inc
13.35. Bluefish Pharmaceuticals AB
13.36. AstraZeneca Plc
13.37. Navamedic ASA
13.38. Beacons Pharmaceuticals Pte Ltd
13.39. Abbott Laboratories SA
13.40. Adcock Ingram Holdings Ltd
13.41. Dongkook Pharmaceutical Co Ltd
13.42. JW Holdings Corp
13.43. Hanmi Pharmaceuticals Co Ltd
13.44. Dong Wha Pharma Co Ltd
13.45. Esteve Pharmaceuticals SA
13.46. Abdi Ibrahim Ilac Sanayi ve Ticaret AS
13.47. Deva Holding AS
13.48. Apotex Inc
13.49. Pharmstandard
13.50. Biocad
13.51. R-Pharm
14 Appendix
14.1. Methodology
14.2. About MarketLine
List of Tables
Table 1: Top 5 emerging countries generics industry, revenue ($m), 2020-29
Table 2: Top 5 emerging countries generics industry, revenue ($m), 2020-24
Table 3: Top 5 emerging countries generics industry forecast, revenue ($m), 2024-29
Table 4: South Africa generics market value: $ million, 2019-24
Table 5: South Africa generics market volume: % of total pharma volume, 2019-24
Table 6: South Africa generics market geography segmentation: $ million, 2024
Table 7: South Africa generics market value forecast: $ million, 2024-29
Table 8: South Africa generics market volume forecast: % of total pharma volume, 2024-29
Table 9: South Africa Size of Population (Million), 2020-24
Table 10: South Africa Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 11: South Africa GDP (Current Prices, $ Billion), 2020-24
Table 12: South Africa Inflation, 2020-24
Table 13: South Africa Consumer Price Index (Absolute), 2020-24
Table 14: South Africa Exchange Rate, 2019-24
Table 15: Brazil generics market value: $ million, 2019-24
Table 16: Brazil generics market volume: % of total pharma volume, 2019-24
Table 17: Brazil generics market geography segmentation: $ million, 2024
Table 18: Brazil generics market value forecast: $ million, 2024-29
Table 19: Brazil generics market volume forecast: % of total pharma volume, 2024-29
Table 20: Brazil Size of Population (Million), 2020-24
Table 21: Brazil Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 22: Brazil GDP (Current Prices, $ Billion), 2020-24
Table 23: Brazil Inflation, 2020-24
Table 24: Brazil Consumer Price Index (Absolute), 2020-24
Table 25: Brazil Exchange Rate, 2019-24
Table 26: China generics market value: $ million, 2019-24
Table 27: China generics market volume: % of total pharma volume, 2019-24
Table 28: China generics market geography segmentation: $ million, 2024
Table 29: China generics market value forecast: $ million, 2024-29
Table 30: China generics market volume forecast: % of total pharma volume, 2024-29
Table 31: China Size of Population (Million), 2020-24
Table 32: China Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 33: China GDP (Current Prices, $ Billion), 2020-24
Table 34: China Inflation, 2020-24
Table 35: China Consumer Price Index (Absolute), 2020-24
Table 36: China Exchange Rate, 2019-24
Table 37: India generics market value: $ million, 2019-24
Table 38: India generics market volume: % of total pharma volume, 2019-24
Table 39: India generics market geography segmentation: $ million, 2024
Table 40: India generics market value forecast: $ million, 2024-29
Table 41: India generics market volume forecast: % of total pharma volume, 2024-29
Table 42: India Size of Population (Million), 2020-24
Table 43: India Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 44: India GDP (Current Prices, $ Billion), 2020-24
Table 45: India Inflation, 2020-24
Table 46: India Consumer Price Index (Absolute), 2020-24
Table 47: India Exchange Rate, 2019-24
Table 48: Mexico generics market value: $ million, 2019-24
Table 49: Mexico generics market volume: % of total pharma volume, 2019-24
Table 50: Mexico generics market geography segmentation: $ million, 2024
Table 51: Mexico generics market value forecast: $ million, 2024-29
Table 52: Mexico generics market volume forecast: % of total pharma volume, 2024-29
Table 53: Mexico Size of Population (Million), 2020-24
Table 54: Mexico Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 55: Mexico GDP (Current Prices, $ Billion), 2020-24
Table 56: Mexico Inflation, 2020-24
Table 57: Mexico Consumer Price Index (Absolute), 2020-24
Table 58: Mexico Exchange Rate, 2019-24
Table 59: Sun Pharmaceutical Industries Ltd: Key Facts
Table 60: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 61: Sun Pharmaceutical Industries Ltd: Key Employees
Table 62: Viatris Inc: Key Facts
Table 63: Viatris Inc: Annual Financial Ratios
Table 64: Viatris Inc: Key Employees
Table 65: Novartis AG: Key Facts
Table 66: Novartis AG: Annual Financial Ratios
Table 67: Novartis AG: Key Employees
Table 68: Teva Pharmaceutical Industries Ltd: Key Facts
Table 69: Teva Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 70: Teva Pharmaceutical Industries Ltd: Key Employees
Table 71: Sandoz Group AG: Key Facts
Table 72: Sandoz Group AG: Annual Financial Ratios
Table 73: Sandoz Group AG: Key Employees
Table 74: Hikma Pharmaceuticals Plc: Key Facts
Table 75: Hikma Pharmaceuticals Plc: Annual Financial Ratios
Table 76: Hikma Pharmaceuticals Plc: Key Employees
Table 77: Sanofi: Key Facts
Table 78: Sanofi: Annual Financial Ratios
Table 79: Sanofi: Key Employees
Table 80: Sanofi: Key Employees Continued
Table 81: Les Laboratoires Servier SAS: Key Facts
Table 82: Les Laboratoires Servier SAS: Key Employees
Table 83: Stada Arzneimittel AG: Key Facts
Table 84: Stada Arzneimittel AG: Key Employees
Table 85: Bayer AG: Key Facts
Table 86: Bayer AG: Annual Financial Ratios
Table 87: Bayer AG: Key Employees
Table 88: Bayer AG: Key Employees Continued
Table 89: Bayer AG: Key Employees Continued
Table 90: Lupin Ltd: Key Facts
Table 91: Lupin Ltd: Annual Financial Ratios
Table 92: Lupin Ltd: Key Employees
Table 93: Aspen Pharmacare Holdings Ltd: Key Facts
Table 94: Aspen Pharmacare Holdings Ltd: Annual Financial Ratios
Table 95: Aspen Pharmacare Holdings Ltd: Key Employees
Table 96: EMS SA: Key Facts
Table 97: EMS SA: Key Employees
Table 98: Eurofarma Laboratorios SA: Key Facts
Table 99: Eurofarma Laboratorios SA: Key Employees
Table 100: Ache Laboratorios Farmaceuticos SA: Key Facts
Table 101: Ache Laboratorios Farmaceuticos SA: Key Employees
Table 102: Sino Biopharmaceutical Ltd: Key Facts
Table 103: Sino Biopharmaceutical Ltd: Annual Financial Ratios
Table 104: Sino Biopharmaceutical Ltd: Key Employees
Table 105: Hansoh Pharmaceutical Group Co Ltd: Key Facts
Table 106: Hansoh Pharmaceutical Group Co Ltd: Annual Financial Ratios
Table 107: Hansoh Pharmaceutical Group Co Ltd: Key Employees
Table 108: CSPC Pharmaceutical Group Ltd: Key Facts
Table 109: CSPC Pharmaceutical Group Ltd: Annual Financial Ratios
Table 110: CSPC Pharmaceutical Group Ltd: Key Employees
Table 111: Dr. Reddy's Laboratories Ltd: Key Facts
Table 112: Dr. Reddy's Laboratories Ltd: Annual Financial Ratios
Table 113: Dr. Reddy's Laboratories Ltd: Key Employees
Table 114: Cipla Ltd: Key Facts
Table 115: Cipla Ltd: Annual Financial Ratios
Table 116: Cipla Ltd: Key Employees
Table 117: Aurobindo Pharma Ltd: Key Facts
Table 118: Aurobindo Pharma Ltd: Annual Financial Ratios
Table 119: Aurobindo Pharma Ltd: Key Employees
Table 120: Aurobindo Pharma Ltd: Key Employees Continued
Table 121: PT Indofarma Tbk: Key Facts
Table 122: PT Indofarma Tbk: Annual Financial Ratios
Table 123: PT Sanbe Farma: Key Facts
Table 124: PT Sanbe Farma: Key Employees
Table 125: PT Kalbe Farma Tbk: Key Facts
Table 126: PT Kalbe Farma Tbk: Annual Financial Ratios
Table 127: PT Kalbe Farma Tbk: Key Employees
Table 128: PT Soho Global Health Tbk: Key Facts
Table 129: PT Soho Global Health Tbk: Annual Financial Ratios
Table 130: PT Soho Global Health Tbk: Key Employees
Table 131: Friulchem SpA: Key Facts
Table 132: Friulchem SpA: Key Employees
Table 133: DOC Generici SRL: Key Facts
Table 134: DOC Generici SRL: Key Employees
Table 135: Recordati SpA: Key Facts
Table 136: Recordati SpA: Annual Financial Ratios
Table 137: Recordati SpA: Key Employees
Table 138: Daiichi Sankyo Co Ltd: Key Facts
Table 139: Daiichi Sankyo Co Ltd: Annual Financial Ratios
Table 140: Daiichi Sankyo Co Ltd: Key Employees
Table 141: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 142: Sawai Group Holdings Co Ltd: Key Facts
Table 143: Sawai Group Holdings Co Ltd: Annual Financial Ratios
Table 144: Sawai Group Holdings Co Ltd: Key Employees
Table 145: Toho Holdings Co Ltd: Key Facts
Table 146: Toho Holdings Co Ltd: Annual Financial Ratios
Table 147: Toho Holdings Co Ltd: Key Employees
Table 148: Towa Pharmaceutical Co Ltd: Key Facts
Table 149: Towa Pharmaceutical Co Ltd: Annual Financial Ratios
Table 150: Towa Pharmaceutical Co Ltd: Key Employees
Table 151: Towa Pharmaceutical Co Ltd: Key Employees Continued
Table 152: Laboratorios Silanes SA de CV: Key Facts
Table 153: Pfizer Inc: Key Facts
Table 154: Pfizer Inc: Annual Financial Ratios
Table 155: Pfizer Inc: Key Employees
Table 156: Pfizer Inc: Key Employees Continued
Table 157: Bluefish Pharmaceuticals AB: Key Facts
Table 158: Bluefish Pharmaceuticals AB: Key Employees
Table 159: AstraZeneca Plc: Key Facts
Table 160: AstraZeneca Plc: Annual Financial Ratios
Table 161: AstraZeneca Plc: Key Employees
Table 162: Navamedic ASA: Key Facts
Table 163: Navamedic ASA: Annual Financial Ratios
Table 164: Navamedic ASA: Key Employees
Table 165: Beacons Pharmaceuticals Pte Ltd: Key Facts
Table 166: Abbott Laboratories SA: Key Facts
Table 167: Adcock Ingram Holdings Ltd: Key Facts
Table 168: Adcock Ingram Holdings Ltd: Key Employees
Table 169: Dongkook Pharmaceutical Co Ltd: Key Facts
Table 170: Dongkook Pharmaceutical Co Ltd: Annual Financial Ratios
Table 171: Dongkook Pharmaceutical Co Ltd: Key Employees
Table 172: JW Holdings Corp: Key Facts
Table 173: JW Holdings Corp: Annual Financial Ratios
Table 174: JW Holdings Corp: Key Employees
Table 175: Hanmi Pharmaceuticals Co Ltd: Key Facts
Table 176: Hanmi Pharmaceuticals Co Ltd: Annual Financial Ratios
Table 177: Hanmi Pharmaceuticals Co Ltd: Key Employees
Table 178: Dong Wha Pharma Co Ltd: Key Facts
Table 179: Dong Wha Pharma Co Ltd: Annual Financial Ratios
Table 180: Dong Wha Pharma Co Ltd: Key Employees
Table 181: Esteve Pharmaceuticals SA: Key Facts
Table 182: Esteve Pharmaceuticals SA: Key Employees
Table 183: Abdi Ibrahim Ilac Sanayi ve Ticaret AS: Key Facts
Table 184: Abdi Ibrahim Ilac Sanayi ve Ticaret AS: Key Employees
Table 185: Deva Holding AS: Key Facts
Table 186: Deva Holding AS: Annual Financial Ratios
Table 187: Deva Holding AS: Key Employees
Table 188: Apotex Inc: Key Facts
Table 189: Apotex Inc: Key Employees
Table 190: Pharmstandard: Key Facts
Table 191: Pharmstandard: Key Employees
Table 192: Biocad: Key Facts
Table 193: Biocad: Key Employees
Table 194: R-Pharm: Key Facts
Table 195: R-Pharm: Key Employees
List of Figures
Figure 1: Top 5 emerging countries generics industry, revenue ($m), 2020-29
Figure 2: Top 5 emerging countries generics industry, revenue ($m), 2020-24
Figure 3: Top 5 emerging countries generics industry forecast, revenue ($m), 2024-29
Figure 4: South Africa generics market value: $ million, 2019-24
Figure 5: South Africa generics market volume: % of total pharma volume, 2019-24
Figure 6: South Africa generics market geography segmentation: % share, by value, 2024
Figure 7: South Africa generics market value forecast: $ million, 2024-29
Figure 8: South Africa generics market volume forecast: % of total pharma volume, 2024-29
Figure 9: Forces driving competition in the generics market in South Africa, 2024
Figure 10: Drivers of buyer power in the generics market in South Africa, 2024
Figure 11: Drivers of supplier power in the generics market in South Africa, 2024
Figure 12: Factors influencing the likelihood of new entrants in the generics market in South Africa, 2024
Figure 13: Factors influencing the threat of substitutes in the generics market in South Africa, 2024
Figure 14: Drivers of degree of rivalry in the generics market in South Africa, 2024
Figure 15: Brazil generics market value: $ million, 2019-24
Figure 16: Brazil generics market volume: % of total pharma volume, 2019-24
Figure 17: Brazil generics market geography segmentation: % share, by value, 2024
Figure 18: Brazil generics market value forecast: $ million, 2024-29
Figure 19: Brazil generics market volume forecast: % of total pharma volume, 2024-29
Figure 20: Forces driving competition in the generics market in Brazil, 2024
Figure 21: Drivers of buyer power in the generics market in Brazil, 2024
Figure 22: Drivers of supplier power in the generics market in Brazil, 2024
Figure 23: Factors influencing the likelihood of new entrants in the generics market in Brazil, 2024
Figure 24: Factors influencing the threat of substitutes in the generics market in Brazil, 2024
Figure 25: Drivers of degree of rivalry in the generics market in Brazil, 2024
Figure 26: China generics market value: $ million, 2019-24
Figure 27: China generics market volume: % of total pharma volume, 2019-24
Figure 28: China generics market geography segmentation: % share, by value, 2024
Figure 29: China generics market value forecast: $ million, 2024-29
Figure 30: China generics market volume forecast: % of total pharma volume, 2024-29
Figure 31: Forces driving competition in the generics market in China, 2024
Figure 32: Drivers of buyer power in the generics market in China, 2024
Figure 33: Drivers of supplier power in the generics market in China, 2024
Figure 34: Factors influencing the likelihood of new entrants in the generics market in China, 2024
Figure 35: Factors influencing the threat of substitutes in the generics market in China, 2024
Figure 36: Drivers of degree of rivalry in the generics market in China, 2024
Figure 37: India generics market value: $ million, 2019-24
Figure 38: India generics market volume: % of total pharma volume, 2019-24
Figure 39: India generics market geography segmentation: % share, by value, 2024
Figure 40: India generics market value forecast: $ million, 2024-29
Figure 41: India generics market volume forecast: % of total pharma volume, 2024-29
Figure 42: Forces driving competition in the generics market in India, 2024
Figure 43: Drivers of buyer power in the generics market in India, 2024
Figure 44: Drivers of supplier power in the generics market in India, 2024
Figure 45: Factors influencing the likelihood of new entrants in the generics market in India, 2024
Figure 46: Factors influencing the threat of substitutes in the generics market in India, 2024
Figure 47: Drivers of degree of rivalry in the generics market in India, 2024
Figure 48: Mexico generics market value: $ million, 2019-24
Figure 49: Mexico generics market volume: % of total pharma volume, 2019-24
Figure 50: Mexico generics market geography segmentation: % share, by value, 2024
Figure 51: Mexico generics market value forecast: $ million, 2024-29
Figure 52: Mexico generics market volume forecast: % of total pharma volume, 2024-29
Figure 53: Forces driving competition in the generics market in Mexico, 2024
Figure 54: Drivers of buyer power in the generics market in Mexico, 2024
Figure 55: Drivers of supplier power in the generics market in Mexico, 2024
Figure 56: Factors influencing the likelihood of new entrants in the generics market in Mexico, 2024
Figure 57: Factors influencing the threat of substitutes in the generics market in Mexico, 2024
Figure 58: Drivers of degree of rivalry in the generics market in Mexico, 2024
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security